Explore the significant impact of obesity on multiple sclerosis (MS) progression, including increased symptoms, disability, and comorbidities. Learn how to manage weight effectively with professional ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

As the multiple sclerosis (MS) population ages, managing the condition can bring new challenges. For one woman, working closely with her doctor, exploring treatment options, and finding the right ...

Over one-third of MS patients do not fully recover post-relapse, with severity as the strongest predictor of incomplete recovery. Relapse-associated worsening (RAW) is crucial in understanding ...

It’s easy to assume that you’d know when you’re dealing with a disease as serious as multiple sclerosis. But it can take years for people with MS to get a proper diagnosis. Now, new research suggests ...

MS patients have increased risks of developing other autoimmune diseases, necessitating careful treatment planning to balance efficacy and risk. Dimethyl fumarate, anti-CD20 antibodies, and ozanimod ...

Cognitive biases impact how both patients and non-patients think about MS, says columnist Ben Hofmeister, who calls education the best remedy.

Multiple sclerosis (MS) is a chronic, often progressive disease that affects the central nervous system, including the brain, spinal cord, and optic nerves. While the most common symptoms include ...

TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative ...

With ads everywhere for pro- or pre-biotic foods and supplements, most people are familiar with the gut microbiome-the trillions of bacteria, fungi, and viruses that colonize our digestive tract-and ...

Joint Clinical Study with Massachusetts General Hospital Could Pave the Way for Testing Efficacy of Quantum’s Investigational MS drug, Lucid-21-302 TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Quantum ...